Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|March 2, 2013
In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantationYoshinobu Kanda, Kumi Oshima, Shinichi Kako, et al.
American Journal of Clinical Pathology|August 26, 2022
Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal EvolutionAkira Matsuda, Kazunori Imada, Naoshi Obara, et al.
International Journal of Hematology|June 12, 2019
Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapyHirohito Yamazaki, Kensuke Ohta, Hiroatsu Iida, et al.
International Journal of Hematology|August 7, 2015
A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantationHaruka Nomoto, Akiyoshi Takami, J Luis Espinoza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell TransplantationJunya Kanda, Tatsuo Ichinohe, Shigeo Fuji, et al.
Transplantation and Cellular Therapy|May 8, 2021
Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor ProgramYoshinobu Kanda, Masami Inoue, Naoyuki Uchida, et al.
Cancers|February 16, 2020
Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk PatientsTomohiro Horio, Eriko Morishita, Shohei Mizuno, et al.
Blood|March 5, 2014
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemiaShuichi Mizuta, Keitaro Matsuo, Satoshi Nishiwaki, et al.
American Journal of Hematology|April 9, 2015
A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatchShigeo Fuji, Junya Kanda, Shunichi Kato, et al.
Cancer Science|February 28, 2012
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 studyKazunori Ohnishi, Chiaki Nakaseko, Jin Takeuchi, et al.
Pageof 16